129 related articles for article (PubMed ID: 1979635)
1. Antihypertensive effect of bopindolol: a multi-centre study.
Török E; Szám I; Buday G; Kerkovits G; Farsang C; Hajtman B
J Hum Hypertens; 1990 Aug; 4(4):458-60. PubMed ID: 1979635
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
4. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
Kirch W; Axthelm T
Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the antihypertensive effects of bopindolol and metoprolol in the treatment of arterial hypertension].
Bagatin J; Kuzmanić A; Rumboldt Z; Mirić D; Naranca M; Obad M; Pivac N; Polić S; Rakić D
Med Pregl; 1990; 43(3-4):145-8. PubMed ID: 1978233
[TBL] [Abstract][Full Text] [Related]
6. [Beta receptor block versus calcium antagonism. A comparative study of bopindolol and nifedipine with special regard to quality of life].
Welzel D; Bräutigam M
Arzneimittelforschung; 1989 Apr; 39(4):499-503. PubMed ID: 2568838
[TBL] [Abstract][Full Text] [Related]
7. The antihypertensive effect of atenolol and bopindolol in the elderly.
Viskoper RJ; Laszt A; Oren S; Hochberg Y; Villa Y; Drexler I; Bregman L; Mishal J
Neth J Med; 1989 Oct; 35(3-4):185-91. PubMed ID: 2574832
[TBL] [Abstract][Full Text] [Related]
8. [The antihypertensive efficacy and tolerance of bopindolol (LT 31-200) in hypertensive patients].
Honorato J; Galende I; Catalán M; Azanza JR
Rev Med Univ Navarra; 1990; 34(2):90-4. PubMed ID: 1983366
[TBL] [Abstract][Full Text] [Related]
9. MIS (Multicentric Isradipine Study of antihypertensive therapy).
Widimský J; Dzúrik R; Fetkovská N; Balazovjech I; Kvasnicka J; Lupínek Z; Mayer O; Pidrman V
Cor Vasa; 1992; 34(1):4-14. PubMed ID: 1363224
[TBL] [Abstract][Full Text] [Related]
10. Acute and long-term antihypertensive effect of bopindolol--a nonselective beta-adrenergic blocker with ISA.
Andersson OK; Hedner T; Nyberg G
Eur J Clin Pharmacol; 1985; 29(3):281-5. PubMed ID: 2866965
[TBL] [Abstract][Full Text] [Related]
11. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive treatment with bopindolol alone or combined with a diuretic in general practice.
Weidmann P; Bousquet JC
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S80-7. PubMed ID: 2439828
[TBL] [Abstract][Full Text] [Related]
13. [The effect of the blood pressure lowering effect of bopindolol (Sandonorm) in patients with mild and moderate hypertension].
Zsáry A; Káldi N; Kállay K
Orv Hetil; 1991 Sep; 132(39):2149-51. PubMed ID: 1681490
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
Velasco M; Morillo J; Urbina A; Kögler P; Leishman B; Pasquier M; Hernändez-Pieretti O
Int J Clin Pharmacol Res; 1987; 7(6):443-54. PubMed ID: 3440635
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
Harder S; Rietbrock S; Thürmann P
Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
[TBL] [Abstract][Full Text] [Related]
16. Twice-daily nicardipine in the treatment of essential hypertension.
Charlap S; Kimmel B; Laifer L; Weinberg P; Singer M; Lazar E; Saltzberg S; Dorsa F; Kafka K; Strom J
J Clin Hypertens; 1986 Sep; 2(3):271-7. PubMed ID: 3537214
[TBL] [Abstract][Full Text] [Related]
17. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
Bouvier JM; Rabot D; Herrero G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
[TBL] [Abstract][Full Text] [Related]
18. Dose-finding study with bopindolol in arterial hypertension.
Willimann P; Peter R; Siegenthaler H
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814
[TBL] [Abstract][Full Text] [Related]
19. [Multicenter study of isradipine in the treatment of hypertension].
Widimský J; Dzúrik R; Fet'kovská N; Balazovjech I; Kvasnicka J; Lupínek Z; Mayer O; Pidrman V
Vnitr Lek; 1992 Apr; 38(4):317-25. PubMed ID: 1352927
[TBL] [Abstract][Full Text] [Related]
20. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]